---
figid: PMC10870057__CTM2-14-e1567-g001
figtitle: Molecular regulatory mechanisms of dormant PGCCs
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10870057
filename: CTM2-14-e1567-g001.jpg
figlink: /pmc/articles/PMC10870057/figure/F2
number: F2
caption: Molecular regulatory mechanisms of dormant PGCCs. Cancer cells enter a dormant
  state and resist various stressors by maintaining a cell cycle arrest. PGCCs possess
  major characteristics of dormant cancer cells, including cell cycle arrest. PGCCs
  represent a dormant form of the stress‐induced cancer cell cycle. PGCCs‐related
  signalling pathways were consistent with the molecular characteristics of dormant
  cells. Alterations in several cell cycle‐related proteins (PLK1, AURKA/B, P53, CHK1,
  CHK2, Cdc42, PAK1, Stathmin, p21, ATM, ATR, p38MAPK, ERK, CDK1, cyclinB1 and CD133)
  may maintain PGCCs dormancy
papertitle: 'Dormant cancer cells and polyploid giant cancer cells: The roots of cancer
  recurrence and metastasis'
reftext: Yuqi Jiao, et al. Clin Transl Med. 2024 Feb;14(2).
year: '2024'
doi: 10.1002/ctm2.1567
journal_title: Clinical and Translational Medicine
journal_nlm_ta: Clin Transl Med
publisher_name: John Wiley and Sons Inc.
keywords: cell cycle arrest | dormancy | endoreduplication | polyploid giant cancer
  cells
automl_pathway: 0.9468081
figid_alias: PMC10870057__F2
figtype: Figure
redirect_from: /figures/PMC10870057__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10870057__CTM2-14-e1567-g001.html
  '@type': Dataset
  description: Molecular regulatory mechanisms of dormant PGCCs. Cancer cells enter
    a dormant state and resist various stressors by maintaining a cell cycle arrest.
    PGCCs possess major characteristics of dormant cancer cells, including cell cycle
    arrest. PGCCs represent a dormant form of the stress‐induced cancer cell cycle.
    PGCCs‐related signalling pathways were consistent with the molecular characteristics
    of dormant cells. Alterations in several cell cycle‐related proteins (PLK1, AURKA/B,
    P53, CHK1, CHK2, Cdc42, PAK1, Stathmin, p21, ATM, ATR, p38MAPK, ERK, CDK1, cyclinB1
    and CD133) may maintain PGCCs dormancy
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CHEK2
  - CDC42
  - PROM1
  - CDH1
  - FZR1
  - AURKA
  - CDC25C
  - AURKB
  - EPHB2
  - MAPK1
  - MAPK3
  - CRK
  - MAPK14
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - NR2F1
  - MYC
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - SOX2
  - RGS2
  - RIEG2
  - MAPK8
  - MAPK9
  - MAPK10
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - CDKL1
  - CDKL2
  - CDKL3
  - CDKL4
  - CDKL5
  - CDK3
  - CDK4
  - CDK5
  - CDK6
  - CDK7
  - CDK8
  - CDK9
  - CDK10
  - CDK11A
  - CDK11B
  - CDK12
  - CDK13
  - CDK14
  - CDK15
  - CDK16
  - CDK17
  - CDK18
  - CDK19
  - CDK20
  - CDK1
  - CDK2
  - TP53
  - TP63
  - TP73
  - RB1
  - CD5L
  - CD69
  - DNMT1
  - ATR
  - ANTXR1
  - MMAB
  - SERPINA2
  - CDK inhibitors
  - AIM
---
